{"date":"2026-07-07","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6645-2026-07-07-1838-13slwxg","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-07-07","time":"18:38:11","subject":"本公司受邀參加創投公會年會「臺灣證券交易所專場」之法人說明會","clause":"第12款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-07-07 18:38，「本公司受邀參加創投公會年會「臺灣證券交易所專場」之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-07-07-1836-9o45wp","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"18:36:45","subject":"代重要子公司大江生醫生物技術(上海)有限公司公告資金貸與予TCI Biotech USA LLC一案","clause":"第23款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-07-07 18:36，「代重要子公司大江生醫生物技術(上海)有限公司公告資金貸與予TCI Biotech USA LLC一案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-07-07-1835-12rln0v","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"18:35:05","subject":"本公司第八次買回公司股份期間屆滿及執行狀況","clause":"第35款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-07-07 18:35，「本公司第八次買回公司股份期間屆滿及執行狀況」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-07-07-1834-4qfdeq","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"18:34:46","subject":"公告本公司董事會訂定除權息基準日","clause":"第14款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-07-07 18:34，「公告本公司董事會訂定除權息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-07-07-1814-jtk0y5","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"18:14:57","subject":"說明本公司之官網於今天下午遭受網路駭客攻擊","clause":"第26款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-07-07 18:14，「說明本公司之官網於今天下午遭受網路駭客攻擊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-07-07-1726-g95olb","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-07-07","time":"17:26:49","subject":"公告本公司臺灣高等法院114年度金上字第40號返還投資款事件之民事訴訟判決。(對應114年8月7日公告)","clause":"第2款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-07-07 17:26，「公告本公司臺灣高等法院114年度金上字第40號返還投資款事件之民事訴訟判決。(對應114年8月7日公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-07-07-1717-xgdzmc","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-07-07","time":"17:17:27","subject":"公告本公司開發治療思覺失調症之505(b)(2)新藥AX251a取得台灣專利","clause":"第44款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-07-07 17:17，「公告本公司開發治療思覺失調症之505(b)(2)新藥AX251a取得台灣專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-07-07-1634-1mwt9vj","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-07-07","time":"16:34:48","subject":"本公司委託國際性CRO公司Novotech執行GNTbm-38的多國多中心臨床一期試驗","clause":"第8款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-07-07 16:34，「本公司委託國際性CRO公司Novotech執行GNTbm-38的多國多中心臨床一期試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-07-07-1628-xo0a4y","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"16:28:35","subject":"公告本公司“膠原再生薄膜”、“膠原蛋白骨填料”、“膠原蛋白基質”取得泰國醫療器材CLASS 4上市許可","clause":"第44款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-07-07 16:28，「公告本公司“膠原再生薄膜”、“膠原蛋白骨填料”、“膠原蛋白基質”取得泰國醫療器材CLASS 4上市許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-07-07-1542-mpsg9g","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"15:42:28","subject":"代重要子公司曜胜生技股份有限公司公告董事會決議115年現金配息基準日","clause":"第14款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-07-07 15:42，「代重要子公司曜胜生技股份有限公司公告董事會決議115年現金配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-07-07-1528-1vlejqa","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-07-07","time":"15:28:57","subject":"本公司受邀參加2026台灣創投暨私募投資年會-證交所專場之法人說明會","clause":"第12款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-07-07 15:28，「本公司受邀參加2026台灣創投暨私募投資年會-證交所專場之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-07-07-1526-1kpakjm","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-07-07","time":"15:26:04","subject":"公告本公司修正114年度年報部份內容","clause":"第44款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-07-07 15:26，「公告本公司修正114年度年報部份內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-07-07-1524-pwqyv8","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-07-07","time":"15:24:11","subject":"公告本公司董事長訂定民國115年第一季除息基準日等相關事宜","clause":"第14款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-07-07 15:24，「公告本公司董事長訂定民國115年第一季除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-07-07-1456-164s3xk","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-07-07","time":"14:56:38","subject":"公告本公司115年現金股利配息基準日","clause":"第14款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-07-07 14:56，「公告本公司115年現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-07-07-1433-150vots","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"14:33:49","subject":"本受邀參加櫃買中心與富邦證券合作舉辦之亞州生技大展法人說明會","clause":"第12款","fact_date":"2026-07-16","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-07-07 14:33，「本受邀參加櫃買中心與富邦證券合作舉辦之亞州生技大展法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-07-07-1428-a8b8vj","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-07-07","time":"14:28:16","subject":"公告本公司董事長訂定配息基準日及調整配息率更正最後過戶日","clause":"第14款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-07-07 14:28，「公告本公司董事長訂定配息基準日及調整配息率更正最後過戶日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-07-07-1413-10rvv55","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-07-07","time":"14:13:33","subject":"更正115年股東常會議事錄(頁次83)","clause":"第53款","fact_date":"2026-07-07","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-07-07 14:13，「更正115年股東常會議事錄(頁次83)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}